COVID-19 and a Window of Opportunity: Guiding Principles for a Health-Promoting Trade Agenda

Document Type : Viewpoint


1 California State University, Fullerton, Fullerton, CA, USA

2 Norwegian University of Science and Technology, Trondheim, Norway

3 University of Nevada, Reno, Reno, NV, USA

4 Department of Anesthesiology, Division of Infectious Disease and Global Public Health, School of Medicine, University of California, San Diego, San Diego, CA, USA

5 Global Health Policy and Data Institute, San Diego, CA, USA


Main Subjects

The human and economic toll of coronavirus disease 2019 (COVID-19) has been devastating; as of November 2020, 190 countries have reported nearly 55 million cases of COVID-19 and over one million deaths.1 The impacts of COVID-19, however, extend far beyond individual and population-level health, as its disruption to the international trade system has had devastating economic effects2; paradoxically, the very rules that govern international trade may pose barriers to states enacting COVID-19 responses that would stabilize international trade... (Read more...)


  1. Johns Hopkins Coronoavirus Resource Center. COVID-19 Map. Global Map.  Accessed November 16, 2020.
  2. World Trade Organization (WTO). Trade Falls Steeply in First Half of 2020. WTO; 2020.  Accessed September 28, 2020.
  3. World Trade Organization (WTO). Trade in Medical Goods in the Context of Tackling COVID-19. WTO; 2020. Accessed November 19, 2020.
  4. World Trade Organization (WTO). Export Prohibitions and Restrictions. WTO; 2020.  Accessed November 18, 2020.
  5. World Bank. The Global Economic Outlook During the COVID-19 Pandemic: A Changed World. World Bank; 2020.   Accessed September 28, 2020.
  6. Urata S, Narjoko DA. Interntional Trade and Inequality. Tokyo: Asian Development Bank Institute; 2017.
  7. Shaffer ER, Waitzkin H, Brenner J, Jasso-Aguilar R. Global trade and public health. Am J Public Health. 2005;95(1):23-34. doi:10.2105/ajph.2004.038091
  8. Labonté R, Crosbie E, Gleeson D, McNamara C. USMCA (NAFTA 2.0): tightening the constraints on the right to regulate for public health. Global Health. 2019;15(1):35. doi:10.1186/s12992-019-0476-8
  9. Crosbie E, Eckford R, Bialous S. Containing diffusion: the tobacco industry's multipronged trade strategy to block tobacco standardised packaging. Tob Control. 2019;28(2):195-205. doi:10.1136/tobaccocontrol-2017-054227
  10. Bernasconi-Osterwalder N, Brewin S, Maina N. Protecting Against Investor-State Claims Amidst COVID-19: A Call to Action for Governments  Accessed November 16, 2020. Published 2020.
  11. United Nations Conference on Trade and Development (UNCTAD). Investment Policy Responses to the COVID-19 Pandemic. UNCTAD; 2020.  Accessed November 16, 2020.
  12. Investment Dispute Settlement Navigator. UNCTAD; 2020. Updated December 31, 2019. Accessed November 16, 2020.
  13. Guven B, Johnson L. The Policy Implications of Third-Party Fundingin Investor-State Dispute Settlement.  Accessed November 16, 2020. Published 2019.
  14. Baxi SM, Beall R, Yang J, Mackey TK. A multidisciplinary review of the policy, intellectual property rights, and international trade environment for access and affordability to essential cancer medications. Global Health. 2019;15(1):57. doi:10.1186/s12992-019-0497-3
  15. World Trade Organization (WTO). Members Discuss Intellectual Property Response to the COVID-19 Pandemic. WTO; 2020.  Accessed November 16, 2020.
  16. Médecins Sans Frontières (MSF). India and South Africa Proposal for WTO Waiver from Intellectual Property Protections for COVID-19-Related Medical Technologies. MSF; 2020.  Accessed November 16, 2020.
  17. ACAFREMIN, Action Aid, Africa Europe Faith & Justice Network, et al. Open Letter to Governments on ISDS and COVID-19.  Access November 18. 2020. Published 2020.
  18. Abbott FM. The TRIPS Agreement Article 73 Security Exceptions and the COVID-19 Pandemic.  Accessed November 18, 2020. Published 2020.
  19. Fazal TM. Health diplomacy in pandemical times. Int Organ. 2020;74(Suppl):1-20. doi:10.1017/s0020818320000326
  20. Jean S. How the COVID-19 pandemic is reshaping the trade landscape and what to do about it. Inter Econ. 2020;55(3):135-139. doi:10.1007/s10272-020-0890-4
  21. Kohler JC, Mackey TK. Why the COVID-19 pandemic should be a call for action to advance equitable access to medicines. BMC Med. 2020;18(1):193. doi:10.1186/s12916-020-01661-3
  22. COVAX. Gavi website.  Accessed November 19, 2020.
  23. Cheng M, Hinnant L. Push to Bring Coronavirus Vaccines to the Poor Faces Trouble. Associated Press. September 3, 2020.  Accessed November 16, 2020.
  24. Kupferschmidt K. 'Vaccine Nationalism’ Threatens Global Plan to Distribute COVID-19 Shots Fairly. Science; 2020.  Accessed November 16, 2020.
Volume 11, Issue 8
August 2022
Pages 1604-1607
  • Receive Date: 04 November 2020
  • Revise Date: 19 November 2020
  • Accept Date: 25 November 2020
  • First Publish Date: 05 December 2020